Discovering a binary CTCF code with a little help from BORIS

ABSTRACT CCCTC-binding factor (CTCF) is a conserved, essential regulator of chromatin architecture containing a unique array of 11 zinc fingers (ZFs). Gene duplication and sequence divergence during early amniote evolution generated the CTCF paralog Brother Of the Regulator of Imprinted Sites (BORIS), which has a DNA binding specificity identical to that of CTCF but divergent N- and C-termini. While healthy somatic tissues express only CTCF, CTCF and BORIS are normally co-expressed in meiotic and post-meiotic germ cells, and aberrant activation of BORIS occurs in tumors and some cancer cell lines. This has led to a model in which CTCF and BORIS compete for binding to some but not all genomic target sites; however, regulation of CTCF and BORIS genomic co-occupancy is not well understood. We recently addressed this issue, finding evidence for two major classes of CTCF target sequences, some of which contain single CTCF target sites (1xCTSes) and others containing two adjacent CTCF motifs (2xCTSes). The functional and chromatin structural features of 2xCTSes are distinct from those of 1xCTS-containing regions bound by a CTCF monomer. We suggest that these previously overlooked classes of CTCF binding regions may have different roles in regulating diverse chromatin-based phenomena, and may impact our understanding of heritable epigenetic regulation in cancer cells and normal germ cells.

[1]  Jennifer E. Phillips-Cremins,et al.  Crossed wires: 3D genome misfolding in human disease , 2017, The Journal of cell biology.

[2]  Victor V Lobanenkov,et al.  The downregulation of putative anticancer target BORIS/CTCFL in an addicted myeloid cancer cell line modulates the expression of multiple protein coding and ncRNA genes , 2017, Oncotarget.

[3]  L. Mirny,et al.  Targeted Degradation of CTCF Decouples Local Insulation of Chromosome Domains from Genomic Compartmentalization , 2017, Cell.

[4]  R. Young,et al.  A Phase Separation Model for Transcriptional Control , 2017, Cell.

[5]  Victor V Lobanenkov,et al.  Testis-specific transcriptional regulators selectively occupy BORIS-bound CTCF target regions in mouse male germ cells , 2017, Scientific Reports.

[6]  I. Petersen,et al.  Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking , 2016, Nature Genetics.

[7]  Victor V Lobanenkov,et al.  The cancer-associated CTCFL/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements , 2016, Epigenetics & Chromatin.

[8]  E. Nora,et al.  CTCF and Cohesin in Genome Folding and Transcriptional Gene Regulation. , 2016, Annual review of genomics and human genetics.

[9]  J. Goodier.  Restricting retrotransposons: a review , 2016, Mobile DNA.

[10]  Shawn M. Gillespie,et al.  Insulator dysfunction and oncogene activation in IDH mutant gliomas , 2015, Nature.

[11]  Daniel S. Day,et al.  Activation of proto-oncogenes by disruption of chromosome neighborhoods , 2015, Science.

[12]  Neva C. Durand,et al.  Chromatin extrusion explains key features of loop and domain formation in wild-type and engineered genomes , 2015, Proceedings of the National Academy of Sciences.

[13]  Bing Ren,et al.  Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions , 2015, Genome Biology.

[14]  Michael Q. Zhang,et al.  CRISPR Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter Function , 2015, Cell.

[15]  Niko Välimäki,et al.  CTCF/cohesin-binding sites are frequently mutated in cancer , 2015, Nature Genetics.

[16]  Julia Zeitlinger,et al.  ChIP-nexus: a novel ChIP-exo protocol for improved detection of in vivo transcription factor binding footprints , 2014, Nature Biotechnology.

[17]  Thomas Abeel,et al.  Decoding ChIP-seq with a double-binding signal refines binding peaks to single-nucleotides and predicts cooperative interaction , 2014, Genome research.

[18]  D. Reinberg,et al.  CTCF regulates the human p53 gene through direct interaction with its natural antisense transcript, Wrap53 , 2014, Genes & development.

[19]  V. Corces,et al.  CTCF: an architectural protein bridging genome topology and function , 2014, Nature Reviews Genetics.

[20]  J. Rasko,et al.  CTCF and BORIS in genome regulation and cancer. , 2014, Current opinion in genetics & development.

[21]  Yoko Ito,et al.  A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells. , 2013, Neoplasia.

[22]  N. Galjart,et al.  The male germ cell gene regulator CTCFL is functionally different from CTCF and binds CTCF-like consensus sites in a nucleosome composition-dependent manner , 2012, Epigenetics & Chromatin.

[23]  B. Pugh,et al.  Comprehensive Genome-wide Protein-DNA Interactions Detected at Single-Nucleotide Resolution , 2011, Cell.

[24]  Chee Seng Chan,et al.  CTCF-Mediated Functional Chromatin Interactome in Pluripotent Cells , 2011, Nature Genetics.

[25]  Victor V Lobanenkov,et al.  Transcription Factor BORIS (Brother of the Regulator of Imprinted Sites) Directly Induces Expression of a Cancer-Testis Antigen, TSP50, through Regulated Binding of BORIS to the Promoter* , 2011, The Journal of Biological Chemistry.

[26]  A. Hoffman,et al.  Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II , 2011, The Journal of cell biology.

[27]  Victor V Lobanenkov,et al.  Cancer-testis antigen, BORIS based vaccine delivered by dendritic cells is extremely effective against a very aggressive and highly metastatic mouse mammary carcinoma. , 2011, Cellular immunology.

[28]  Victor V Lobanenkov,et al.  Expression of a Testis-Specific Form of Gal3st1 (CST), a Gene Essential for Spermatogenesis, Is Regulated by the CTCF Paralogous Gene BORIS , 2010, Molecular and Cellular Biology.

[29]  M. Batzer,et al.  The impact of retrotransposons on human genome evolution , 2009, Nature Reviews Genetics.

[30]  Janine E. Deakin,et al.  The Evolution of Epigenetic Regulators CTCF and BORIS/CTCFL in Amniotes , 2008, PLoS genetics.

[31]  D. Loukinov,et al.  Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors , 2007, Nucleic acids research.

[32]  Michael Q. Zhang,et al.  Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome , 2007, Cell.

[33]  Victor V Lobanenkov,et al.  Allele-Specific Binding of CTCF to the Multipartite Imprinting Control Region KvDMR1 , 2007, Molecular and Cellular Biology.

[34]  M. Vigneron,et al.  CTCF Interacts with and Recruits the Largest Subunit of RNA Polymerase II to CTCF Target Sites Genome-Wide , 2007, Molecular and Cellular Biology.

[35]  Rolf Ohlsson,et al.  CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Loukinov,et al.  CTCF binds the proximal exonic region of hTERT and inhibits its transcription , 2005, Nucleic acids research.

[37]  Victor V Lobanenkov,et al.  Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. , 2005, Cancer research.

[38]  Rolf Ohlsson,et al.  CTCF is conserved from Drosophila to humans and confers enhancer blocking of the Fab‐8 insulator , 2005, EMBO reports.

[39]  Victor V Lobanenkov,et al.  Chromatin Architecture near a Potential 3′ End of the Igh Locus Involves Modular Regulation of Histone Modifications during B-Cell Development and In Vivo Occupancy at CTCF Sites , 2005, Molecular and Cellular Biology.

[40]  C. Disteche,et al.  Boundaries between chromosomal domains of X inactivation and escape bind CTCF and lack CpG methylation during early development. , 2005, Developmental cell.

[41]  Victor V Lobanenkov,et al.  The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. , 2002, Seminars in cancer biology.

[42]  J. J. Breen,et al.  BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Jeannie T. Lee,et al.  CTCF, a Candidate Trans-Acting Factor for X-Inactivation Choice , 2001, Science.

[44]  S. Tapscott,et al.  CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus , 2001, Nature Genetics.

[45]  T. Kouzarides,et al.  Transcriptional repression by the insulator protein CTCF involves histone deacetylases. , 2000, Nucleic acids research.

[46]  A. West,et al.  The Protein CTCF Is Required for the Enhancer Blocking Activity of Vertebrate Insulators , 1999, Cell.

[47]  P. Neiman,et al.  A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers , 1998, Genes, chromosomes & cancer.

[48]  P. Neiman,et al.  CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms , 1993, Molecular and cellular biology.